Our study illustrates a cardiomyocyte-specific USP28-TRIM21 axis in regulating hypertrophic cardiomyopathy and indicates USP28 as a pharmacological target for cardiac hypertrophy. Here, TRIM21 is linked to cardiac hypertrophy.